Selective VPAC2 receptor peptide agonists

Details for Australian Patent Application No. 2006306236 (hide)

Owner Eli Lilly and Company

Inventors Alsina-Fernandez, Jorge; Zhang, Lianshan; Bokvist, Bengt Krister

Agent Spruson & Ferguson

Pub. Number AU-B-2006306236

PCT Pub. Number WO2007/050651

Priority 60/730,291 26.10.05 US; 60/740,342 29.11.05 US; 60/743,364 28.02.06 US

Filing date 24 October 2006

Wipo publication date 3 May 2007

Acceptance publication date 1 December 2011

International Classifications

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050651 Priority application(s): WO2007/050651

1 December 2011 Application Accepted

  Published as AU-B-2006306236

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306240-Combination of histone deacetylase inhibitors and radiation

2006306229-Intervertebral disc replacement and associated instrumentation